Article
Australia's CSL prices hemophilia gene therapy at $3.5 million
Rating:
0.0
Views:
80
Likes:
1
Library:
1
Australian drugmaker CSL Ltd on Tuesday set the list price of its one-time gene therapy for hemophilia B at $3.5 million, making it the world's most expensive treatment, following its approval by the U.S. health regulator.
Rate This Post
Rate The Educational Value
Rate The Ease of Understanding and Presentation
Interesting or Boring? Rate the Entertainment Value